Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: orange book
Cutting Through the Patent Thicket – The Little Bill that Couldn’t
A bill was recently proposed to “reduce the improper issuance of patents that improperly extend the term of exclusivity afforded a new drug or biological product.” The bill would amend the patent statutes (s. 253 or title 35) for add … Continue reading
Posted in Drug Patent Term
Tagged Drug Patent Term, Federal Circuit, Generic Drugs, Hatch-Waxman, orange book, PTAB
Leave a comment
“We Don’t Need No Stinkin’ Patents” – Antibiotic and Antifungal Drugs Gain Non-Patent Exclusivity
Posted on the FDA Law Blog by Kurt Karst on June 19, 2014. After years of relative quiet, the Orange Book list of exclusivity terms has gotten quite a workout over the past year with the addition of several new terms … Continue reading
Posted in Hatch-Waxman
Tagged biotechnology law, Dalvance, FDA Law Blog, Hatch-Waxman, Kurt Karst, orange book, Warren Woessner
Leave a comment
Get Your Application On The Fast Track – For A Price
On Friday, the PTO proposed changes in the rules to permit applicants for U.S. patents to receive “prioritized examination” (76 Fed. Reg. 6370 (Feb. 4 2011) – a copy is attached below). This program is a remnant of the three-track … Continue reading